FIGURE 2.
Percentage of participants categorized as exhibiting remission* and nonremission* based on SDS total score in (top graph) Study 1 and (bottom graph) Study 2, full analysis set
*Remission (no or minimal functional disability) was defined as SDS total score ≤6.
†Nonremission (some level of functional disability) was defined as SDS total score >6.
LDX: lisdexamfetamine dimesylate; PBO: placebo; SDS: Sheehan Disability Scale